Emergent BioSolutions, a US biopharmaceutical company, announced that once its Japanese encephalitis vaccine receives approval from the US Food and Drug Administration, it will officially become the exclusive distributor of the vaccine to the US government.

Emergent BioSolutions, a US biopharmaceutical company, announced that once its Japanese encephalitis vaccine receives approval from the US Food and Drug Administration, it will officially become the exclusive distributor of the vaccine to the US government.

老虎证券2026/04/28 12:11

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This authorization further consolidates Emergent BioSolutions' strategic position in the government medical countermeasures supply sector.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Emergent BioSolutions, a US biopharmaceutical company, announced that once its Japanese encephalitis vaccine receives approval from the US Food and Drug Administration, it will officially become the exclusive distributor of the vaccine to the US government.

You may also like

Crypto prices